Some randomized controlled and observational studies for the withdrawal of tumor necrosis factor inhibitors (TNFi) in rheumatoid arthritis have been conducted [15], suggesting that tapering is feasible. The gene discussed is TNF; the disease is rheumatoid arthritis.